Fabrice Kwiatkowski

14.6k total citations · 2 hit papers
168 papers, 11.3k citations indexed

About

Fabrice Kwiatkowski is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fabrice Kwiatkowski has authored 168 papers receiving a total of 11.3k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Oncology, 41 papers in Cancer Research and 38 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fabrice Kwiatkowski's work include Breast Cancer Treatment Studies (30 papers), Cancer Treatment and Pharmacology (22 papers) and BRCA gene mutations in cancer (15 papers). Fabrice Kwiatkowski is often cited by papers focused on Breast Cancer Treatment Studies (30 papers), Cancer Treatment and Pharmacology (22 papers) and BRCA gene mutations in cancer (15 papers). Fabrice Kwiatkowski collaborates with scholars based in France, United States and Italy. Fabrice Kwiatkowski's co-authors include K. Slim, Yves Panís, J Chipponi, Emile Nini, Damien Forestier, Yves‐Jean Bignon, P. Chollet, Olivier Gléhen, Frédérique Penault‐Llorca and Pierre Verrelle and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Fabrice Kwiatkowski

159 papers receiving 11.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Methodological index for non‐randomized studies (MINORS): development and validation of a new instrument

2003 5.9k citations Fabrice Kwiatkowski et al. profile →
Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis From Colorectal Cancer: A Multi-Institutional Study

2004 899 citations Fabrice Kwiatkowski et al. profile →

Peers

Countries citing papers authored by Fabrice Kwiatkowski

Since Specialization

Citations

This map shows the geographic impact of Fabrice Kwiatkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrice Kwiatkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrice Kwiatkowski more than expected).

Fields of papers citing papers by Fabrice Kwiatkowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabrice Kwiatkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrice Kwiatkowski. The network helps show where Fabrice Kwiatkowski may publish in the future.

Co-authorship network of co-authors of Fabrice Kwiatkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Fabrice Kwiatkowski. A scholar is included among the top collaborators of Fabrice Kwiatkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabrice Kwiatkowski. Fabrice Kwiatkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oncogenetic pedigrees: Relation between design and ability to predict mutation 2023 ·Biosystems ·Fabrice Kwiatkowski, (unknown), (unknown)	1
2	Benefits of using corneal topography to choose subjective refraction technique in keratoconus (RE-CON): a prospective comparative crossover clinical study 2021 ·Graefe s Archive for Clinical and Experimental Ophthalmology ·(unknown), Valentin Navel, (unknown), Fabrice Kwiatkowski, (unknown), Aurélien Mulliez, (unknown), Frédéric Chiambaretta, Fréderic Dutheil	0
3	Effectiveness of a Global Multidisciplinary Supportive and Educational Intervention in Thermal Resort on Anthropometric and Biological Parameters, and the Disease-Free Survival after Breast Cancer Treatment Completion (PACThe) 2020 ·Journal of Oncology ·Marie‐Paule Vasson, Fabrice Kwiatkowski, Adrien Rossary, (unknown), Marie‐Ange Mouret‐Reynier, Martine Duclos, (unknown), (unknown), Yves‐Jean Bignon	3
4	Characterisation of gut, lung, and upper airways microbiota in patients with non-small cell lung carcinoma 2018 ·Medicine ·Rea Bingula, Marc Filaire, Nina Radosevic‐Robin, Jean‐Yves Berthon, Annick Bernalier‐Donadille, Marie‐Paule Vasson, Émilie Thivat, Fabrice Kwiatkowski, Edith Filaire	29
5	Long-term improvement of breast cancer survivors’ quality of life by a 2-week group physical and educational intervention: 5-year update of the ‘PACThe’ trial 2017 ·British Journal of Cancer ·Fabrice Kwiatkowski, Marie‐Ange Mouret‐Reynier, Martine Duclos, (unknown), (unknown), (unknown), (unknown), Marie‐Paule Vasson, (unknown), (unknown), Yves‐Jean Bignon	25
6	Combined treatment modalities in Pancoast tumor: results of a monocentric retrospective study. 2015 ·PubMed ·G. Jeannin, P. Merle, Henri Janicot, (unknown), Fabrice Kwiatkowski, (unknown), (unknown), Géraud Galvaing, (unknown), Marc Filaire, Pierre Verrelle	5
7	Is It Important to Adapt Neoadjuvant Chemotherapy to the Visible Clinical Response? An Open Randomized Phase II Study Comparing Response-Guided and Standard Treatments in HER2-Negative Operable Breast Cancer 2015 ·The Oncologist ·(unknown), Marie‐Ange Mouret‐Reynier, Aude-Marie Savoye, Catherine Abrial, Fabrice Kwiatkowski, Christian Garbar, Pascale Dubray‐Longeras, Jean‐Christophe Eymard, (unknown), (unknown), Frédérique Penault‐Llorca, P. Chollet, Hervé Curé	2
8	Adenocarcinoma of the pancreas: Does prognosis depend on mode of lymph node invasion? 2014 ·European Journal of Surgical Oncology ·Emmanuel Buc, Anne Couvelard, Fabrice Kwiatkowski, Safi Dokmak, Philippe Ruszniewski, Pascal Hammel, Jacques Belghiti, Alain Sauvanet	27
9	Long-term improved quality of life by a 2-week group physical and educational intervention shortly after breast cancer chemotherapy completion. Results of the “Programme of Accompanying women after breast Cancer treatment completion in Thermal resorts” (PACTHE) 2014 ·Annals of Physical and Rehabilitation Medicine ·Fabrice Kwiatkowski, Yves‐Jean Bignon, (unknown)	3
10	The role of tomosynthesis in breast cancer staging in 75 patients 2014 ·Diagnostic and Interventional Imaging ·(unknown), Fabrice Kwiatkowski, Catherine Abrial, (unknown), (unknown), (unknown), (unknown), (unknown)	24
11	Epidural versus Continuous Preperitoneal Analgesia during Fast-track Open Colorectal Surgery 2013 ·Anesthesiology ·Philippe Jouve, Jean-Étienne Bazin, (unknown), Vincent Minville, (unknown), Emmanuel Buc, Aurélien Dupré, Fabrice Kwiatkowski, Jean‐Michel Constantin, Emmanuel Futier	44
12	Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse 2010 ·BMC Cancer ·Émilie Thivat, (unknown), Olivier Lapirot, Catherine Abrial, Pierre Gimbergues, Émilie Gadéa, E. Planchat, Fabrice Kwiatkowski, Marie Ange Mouret‐Reynier, P. Chollet, Xavier Durando	92
13	DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort. 2008 ·PubMed ·Luc Fontana, Rémy Bosviel, Laëtitia Delort, Laurent Guy, Nasséra Chalabi, Fabrice Kwiatkowski, Samir Satih, Nadège Rabiau, Jean‐Paul Boiteux, A. Chamoux, Yves‐Jean Bignon, Dominique Bernard-Gallon	46
14	Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy Is Accurate in Breast Cancer Patients with a Clinically Negative Axillary Nodal Status at Presentation 2008 ·Annals of Surgical Oncology ·Pierre Gimbergues, Catherine Abrial, Xavier Durando, G. Le Bouëdec, F. Cachin, Frédérique Penault‐Llorca, M-A Mouret-Reynier, Fabrice Kwiatkowski, J. Maublant, Andréï Tchirkov, J Dauplat	68
15	Traitement de l'hyperthyroïdie du sujet âgé par l'iode 131. A propos de 180 patients. Problèmes de radioprotection et de gestion des déchets liés au traitement par l'iode 131 2005 ·Médecine Nucléaire ·C. Dejax, (unknown), (unknown), Fabrice Kwiatkowski, (unknown), Bernard Aubert	1
16	Pre- and Postoperative Aminoacidemia in Breast Cancer: A Study vs. Matched Healthy Subjects 2004 ·Cancer Investigation ·Régine Minet‐Quinard, Isabelle Van Praagh, Fabrice Kwiatkowski, (unknown), V. Feillel, B. Beaufrère, (unknown), Luc Cynober, Marie‐Paule Vasson	11
17	Hematological recovery and peripheral blood progenitor cell mobilization after induction chemotherapy and GM-CSF plus G-CSF in breast cancer 2000 ·Bone Marrow Transplantation ·Sabine Charrier, P. Chollet, J.-O. Bay, H. Curé, Fabrice Kwiatkowski, (unknown), Yves Communal, (unknown), R Plagne, J Chassagne	2
18	Chrono-pharmacocinétique du 5-fluoro-uracile dans le traitement des cancers colorectaux métastatiques et indicateurs de réponse métabolique 1999 ·Journal de Pharmacie Clinique ·Fabrice Kwiatkowski, (unknown), (unknown), Sabine Charrier, H. Curé, (unknown), (unknown), P. Chollet	1
19	Low grade supratentorial astrocytomas. Management and prognostic factors 1994 ·Cancer ·P Janny, Hervé Curé, (unknown), N Heldt, Fabrice Kwiatkowski, Jean‐Jacques Lemaire, R Plagne, R Rozan	148
20	Clinical Relevance of Immunohistochemical Detection of Multidrug Resistance P-Glycoprotein in Breast Carcinoma 1991 ·JNCI Journal of the National Cancer Institute ·Pierre Verrelle, Frédéric Martinez, Y Fonck, V. Feillel, C Dionet, Fabrice Kwiatkowski, R Plagne, J Chassagne	179

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact